Based on what we found, it suggests that there is a regulatory axis associated with trastuzumab resistance in HER2-positive GC cells: MACC1 enhanced the Warburg effect via the PI3K/AKT signaling pathway. This evidence concerns the gene MACC1 and gastric cancer.